Literature DB >> 29885648

Progressive multiple sclerosis patients have a higher burden of autonomic dysfunction compared to relapsing remitting phenotype.

Ivan Adamec1, Luka Crnošija1, Anamari Junaković1, Magdalena Krbot Skorić1, Mario Habek2.   

Abstract

OBJECTIVE: To determine autonomic dysfunction (AD) differences in patients with relapsing remitting multiple sclerosis (pwRRMS) and progressive MS (pwPMS).
METHODS: Composite autonomic scoring scale (CASS) and heart rate variability (HRV) were performed in 40 pwRRMS and 30 pwPMS.
RESULTS: pwPMS had a significantly higher sudomotor index and total CASS score compared to pwRRMS (p < 0.001 and p < 0.001, respectively). Disease duration positively correlated with sudomotor index and total CASS (rs = 0.409, p < 0.001 and rs = 0.472, p < 0.001, respectively), while the Expanded Disability Status Scale (EDSS) positively correlated with sudomotor index and total CASS (rs = 0.411, p < 0.001 and rs = 0.402, p = 0.001, respectively) in all patients. Type of multiple sclerosis (pwRRMS or pwPMS) corrected for age, sex and disease duration, was a statistically significant predictor of CASS value (B = 1.215, p = 0.019). Compared to pwRRMS, pwPMS had a significantly lower standard deviation of NN intervals (SDNN), low frequency (LF), and high frequency (HF), during both the supine and tilt-up phases (all p-values <0.006). pwPMS had a significantly lower LF/HF (p = 0.008) during tilt-up.
CONCLUSION: There is a significant difference in autonomic function in pwRRMS and pwPMS; with pwPMS having a higher burden of AD, which is particularly evident for sweating dysfunction. SIGNIFICANCE: Further research is needed to establish whether parasympathetic and sudomotor dysfunction may serve as markers of progressive MS.
Copyright © 2018 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autonomic nervous system; Composite autonomic scoring scale; Heart rate variability; Multiple sclerosis; Progressive; Relapsing-remitting

Mesh:

Year:  2018        PMID: 29885648     DOI: 10.1016/j.clinph.2018.05.009

Source DB:  PubMed          Journal:  Clin Neurophysiol        ISSN: 1388-2457            Impact factor:   3.708


  15 in total

Review 1.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

Review 2.  Peripheral nervous system in multiple sclerosis-understanding the involvement via autonomic nervous system.

Authors:  Ivan Adamec; Magdalena Krbot Skorić; Mario Habek
Journal:  Neurol Sci       Date:  2021-05-25       Impact factor: 3.307

3.  Autonomic dysfunction in multiple sclerosis and other updates on recent autonomic research.

Authors:  Mitchell G Miglis; Srikanth Muppidi
Journal:  Clin Auton Res       Date:  2018-07-16       Impact factor: 4.435

Review 4.  Heart rate variability and fatigue in MS: two parallel pathways representing disseminated inflammatory processes?

Authors:  Guadalupe Garis; Michael Haupts; Thomas Duning; Helmut Hildebrandt
Journal:  Neurol Sci       Date:  2022-09-20       Impact factor: 3.830

5.  Cardiovascular autonomic dysfunction in multiple sclerosis-findings and relationships with clinical outcomes and fatigue severity.

Authors:  Łukasz Rzepiński; Monika Zawadka-Kunikowska; Julia L Newton; Paweł Zalewski; Joanna Słomko
Journal:  Neurol Sci       Date:  2022-05-04       Impact factor: 3.830

6.  Unveiling the relationship between autonomic involvement, fatigue, and cognitive dysfunction in early relapsing-remitting multiple sclerosis.

Authors:  Alessandro Dinoto; Sara Baldini; Maria Elisa Morelli; Fulvio Pasquin; Alessio Bratina; Antonio Bosco; Arianna Sartori; Paolo Manganotti
Journal:  Neurol Sci       Date:  2021-08-02       Impact factor: 3.307

7.  Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek
Journal:  Clin Auton Res       Date:  2018-09-12       Impact factor: 4.435

Review 8.  An Overview of Therapeutic Options in Relapsing-remitting Multiple Sclerosis.

Authors:  Sidra Saleem; Arsalan Anwar; Muniba Fayyaz; Fatima Anwer; Faria Anwar
Journal:  Cureus       Date:  2019-07-26

Review 9.  Cardiac Autonomic Dysfunction in Multiple Sclerosis: A Systematic Review of Current Knowledge and Impact of Immunotherapies.

Authors:  Oliver Findling; Larissa Hauer; Thomas Pezawas; Paulus S Rommer; Walter Struhal; Johann Sellner
Journal:  J Clin Med       Date:  2020-01-24       Impact factor: 4.241

10.  Evaluation of cardiovascular autonomic dysfunction according to heart rate turbulence and variability in patients with relapsing remitting multiple sclerosis

Authors:  Serkan Gökaslan; Hayri Demirbaş; Çiğdem Özer Gökaslan
Journal:  Turk J Med Sci       Date:  2020-04-09       Impact factor: 0.973

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.